IP Library Granted Patent US 12,527,500
Granted Patent B2
US 12,527,500 · App. 17/980,018 · Granted Jan 20, 2026

Ketone limiting membrane and dual layer membrane approach for ketone sensing

Inventors: Jenn-Hann L. Wang (Northridge, CA); Anna J. Miller (Woodland Hills, CA); Chi-En Lin (Encino, CA); Melissa Tsang (Los Angeles, CA); Akhil Srinivasan (Woodland Hills, CA); Quyen B. Ong (Arcadia, CA)
Assignee: MEDTRONIC MINIMED, INC.
A61B5/14546A61B5/1486C12Q1/005G01N27/327
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,527,500
App. No.
17/980,018
Granted
Jan 20, 2026
Kind
B2
Abstract

The invention provides amperometric analyte sensor systems comprising one or more electrodes designed to monitor in vivo levels of 3-hydroxybutyrate (and optionally glucose as well) in order to facilitate the management of diabetic ketoacidosis. The invention further includes dual layer membrane compositions, elements and methods useful with such amperometric analyte sensor systems.

Claims (69)

1 . A D-3-hydroxybutyrate analyte sensor comprising a ketone limiting membrane, wherein the ketone limiting membrane comprises:

(a) an inner membrane layer having a first permeability to D-3-hydroxybutyrate and a first permeability to nicotinamide adenine dinucleotide; and

(b) an outer membrane layer having a second permeability to D-3-hydroxybutyrate and a second permeability to nicotinamide adenine dinucleotide; wherein:

the inner membrane layer permeability to nicotinamide adenine dinucleotide is lower than the outer membrane layer permeability to nicotinamide adenine dinucleotide; and

the D-3-hydroxybutyrate analyte sensor further comprises:

a 3-hydroxybutyrate sensing electrode comprising:

a layer of an electroactive material;

an enzyme layer comprising 3-hydroxybutyrate dehydrogenase enzyme in operable contact with the electroactive material;

a nicotinamide adenine dinucleotide in operable contact with the 3-hydroxybutyrate dehydrogenase enzyme; and

a mediator in operable contact with the nicotinamide adenine dinucleotide.

2 . The D-3-hydroxybutyrate analyte sensor of claim 1 , wherein:

(a) the inner membrane exhibits a perm-selectivity of 3-hydroxybutyric acid to nicotinamide adenine dinucleotide (NAD)+hydrogen (H) of at least 50; and/or

(b) the outer membrane exhibits a perm-selectivity of 3-hydroxybutyric acid to nicotinamide adenine dinucleotide (NAD)+hydrogen (H) of at least 1.

3 . The D-3-hydroxybutyrate analyte sensor of claim 1 , wherein:

(a) the inner membrane exhibits a 3-hydroxybutyrate permeability of at least 1.0E-09 cm2/sec;

(b) the inner membrane exhibits a nicotinamide adenine dinucleotide (NAD)+hydrogen (H) permeability not greater than 3.0E-09 cm2/sec;

(c) the outer membrane exhibits a 3-hydroxybutyrate permeability of at least 5.0E-09 cm2/sec; and/or

(d) the outer membrane exhibits a nicotinamide adenine dinucleotide (NAD)+hydrogen (H) permeability not greater than 5.0E-09 cm2/sec.

4 . The D-3-hydroxybutyrate analyte sensor of claim 1 , wherein:

(a) the inner membrane layer is from 0.1 to 5 microns in thickness, and/or

(b) the outer layer is from 2 to 50 microns in thickness.

5 . The D-3-hydroxybutyrate analyte sensor of claim 1 , wherein:

(a) the inner membrane layer comprises cellulose acetate; and

(b) the outer membrane layer comprises a polyurea, a a nine-membered polypropylene glycol compound terminated by an amino group at a first end and a methoxyethyl termination at a second end, a polydimethylsiloxane, and/or 4,4′-Methylenebis (cyclohexyl isocyanate).

6 . The D-3-hydroxybutyrate analyte sensor of claim 1 , wherein:

(a) the inner membrane layer comprises cellulose acetate; and

(b) the outer membrane layer comprises a polyurea-urethane or a polycarbonate-urethane composition containing a nine-membered polypropylene glycol compound terminated by an amino group at a first end and a methoxyethyl termination at a second end, polydimethylsiloxane, 4,4′-Methylenebis (cyclohexyl isocyanate), 4,4′-Methylenebis (phenyl isocyanate), and polycarbonate diol.

7 . A method of estimating the concentrations of 3-hydroxybutyrate in vivo, the method comprising:

disposing a D-3-hydroxybutyrate analyte sensor of claim 1 into an in vivo environment of a subject, wherein the environment comprises 3-hydroxybutyrate; and

estimating the concentration of 3-hydroxybutyrate;

so that the concentrations of 3-hydroxybutyrate in vivo are estimated.

8 . A method of making a D-3-hydroxybutyrate analyte sensor comprising a ketone limiting membrane, the method:

(a) forming an inner membrane layer of the ketone limiting membrane from materials selected to exhibit a first permeability to D-3-hydroxybutyrate and a first permeability to nicotinamide adenine dinucleotide; and

(b) forming an outer membrane layer of the ketone limiting membrane from materials selected to exhibit a second permeability to D-3-hydroxybutyrate and a second permeability to nicotinamide adenine dinucleotide; wherein:

the inner membrane layer permeability to nicotinamide adenine dinucleotide is lower than the outer membrane layer permeability to nicotinamide adenine dinucleotide; and

disposing the ketone limiting membrane on a D-3-hydroxybutyrate analyte sensor at a location selected so that D-3-hydroxybutyrate diffuses from an external environment through the ketone limiting membrane and to an electrode disposed within the D-3-hydroxybutyrate analyte sensor, wherein:

the electrode is coupled to a ketone sensing complex; and

the electrode is formed to comprise:

a layer of an electroactive material;

an enzyme layer comprising 3-hydroxybutyrate dehydrogenase enzyme in operable contact with the electroactive material;

nicotinamide adenine dinucleotide in operable contact with the 3-hydroxybutyrate dehydrogenase enzyme; and

a mediator in operable contact with the nicotinamide adenine dinucleotide.

9 . The method of claim 8 , wherein:

(a) the inner membrane is formed to exhibit a perm-selectivity of 3-hydroxybutyric acid to nicotinamide adenine dinucleotide (NAD)+hydrogen (H) of at least 50; and/or

(b) the outer membrane is formed to exhibit a perm-selectivity of 3-hydroxybutyric acid to nicotinamide adenine dinucleotide (NAD)+hydrogen (H) of at least 1.

10 . The method of claim 8 , wherein:

(a) the inner membrane is formed to exhibit a 3-hydroxybutyrate permeability of at least 1.0E-09 cm2/sec;

(b) the inner membrane is formed to exhibit a nicotinamide adenine dinucleotide (NAD)+hydrogen (H) permeability not greater than 3.0E-09 cm2/sec;

(c) the outer membrane is formed to exhibit a 3-hydroxybutyrate permeability of at least 5.0E-09 cm2/sec; and/or

(d) the outer membrane is formed to exhibit a nicotinamide adenine dinucleotide (NAD)+hydrogen (H) permeability not greater than 5.0E-09 cm2/sec.

11 . The method of claim 8 , wherein:

(a) the inner membrane layer is formed to be from 0.1 to 5 microns in thickness, and/or

(b) the outer layer is formed to be from 2 to 50 microns in thickness.

12 . A D-3-hydroxybutyrate analyte sensor comprising a mediator and a ketone limiting membrane, wherein the ketone limiting membrane comprises:

an inner membrane layer having a first permeability to D-3-hydroxybutyrate and a first permeability to nicotinamide adenine dinucleotide; and

an outer membrane layer having a second permeability to D-3-hydroxybutyrate and a second permeability to nicotinamide adenine dinucleotide; wherein:

the inner membrane layer permeability to nicotinamide adenine dinucleotide is lower than the outer membrane layer permeability to nicotinamide adenine dinucleotide.

13 . A D-3-hydroxybutyrate analyte sensor comprising a ketone limiting membrane, wherein the ketone limiting membrane comprises:

an inner membrane layer having a first permeability to D-3-hydroxybutyrate and a first permeability to nicotinamide adenine dinucleotide; and

an outer membrane layer having a second permeability to D-3-hydroxybutyrate and a second permeability to nicotinamide adenine dinucleotide; wherein:

the inner membrane layer permeability to nicotinamide adenine dinucleotide is lower than the outer membrane layer permeability to nicotinamide adenine dinucleotide;

the inner membrane layer comprises poly (ethylene-vinyl acetate), and

the outer membrane layer comprises polyurea, a nine-membered polypropylene glycol compound terminated by an amino group at a first end and a methoxyethyl termination at a second end, polydimethylsiloxane, and 4,4′-Methylenebis (cyclohexyl isocyanate).

14 . A D-3-hydroxybutyrate analyte sensor comprising a ketone limiting membrane, wherein the ketone limiting membrane comprises:

an inner membrane layer having a first permeability to D-3-hydroxybutyrate and a first permeability to nicotinamide adenine dinucleotide; and

an outer membrane layer having a second permeability to D-3-hydroxybutyrate and a second permeability to nicotinamide adenine dinucleotide; wherein:

the inner membrane layer permeability to nicotinamide adenine dinucleotide is lower than the outer membrane layer permeability to nicotinamide adenine dinucleotide;

the inner membrane layer comprises poly (ethylene-vinyl acetate), and

the outer membrane layer comprises polyurea-urethane containing a nine-membered polypropylene glycol compound terminated by an amino group at a first end and a methoxyethyl termination at a second end, polydimethylsiloxane, 4,4′-Methylenebis (cyclohexyl isocyanate), 4,4′-Methylenebis (phenyl isocyanate), and polycarbonate diol.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2023
From: WANG, JENN-HANN L.; MILLER, ANNA J.; LIN, CHI-EN; TSANG, MELISSA; SRINIVASAN, AKHIL; ONG, QUYEN B.
To: MEDTRONIC MINIMED, INC.
Reel/Frame 062363/0459 →
Continuity (2)
Provisional Application 63285226 · Dec 2, 2021
Related Publication 20230172497A1 · Jun 8, 2023
References Cited (93)
US 4755173A · Konopka et al. · 1988 [cited by applicant]
US 5391250A · Cheney, II et al. · 1995 [cited by applicant]
US 5485408A · Blomquist · 1996 [cited by applicant]
US 5522803A · Teissen-Simony · 1996 [cited by applicant]
US 5665065A · Colman et al. · 1997 [cited by applicant]
US 5800420A · Gross et al. · 1998 [cited by applicant]
US 5807375A · Gross et al. · 1998 [cited by applicant]
US 5925021A · Castellano et al. · 1999 [cited by applicant]
US 5954643A · Van Antwerp et al. · 1999 [cited by applicant]
US 6017328A · Fischell et al. · 2000 [cited by applicant]
US 6186982B1 · Gross et al. · 2001 [cited by applicant]
US 6246992B1 · Brown · 2001 [cited by applicant]
US 6248067B1 · Causey, III et al. · 2001 [cited by applicant]
US 6248093B1 · Moberg · 2001 [cited by applicant]
US 6355021B1 · Nielsen et al. · 2002 [cited by applicant]
US 6379301B1 · Worthington et al. · 2002 [cited by applicant]
US 6544212B2 · Galley et al. · 2003 [cited by applicant]
US 6558351B1 · Steil et al. · 2003 [cited by applicant]
US 6591876B2 · Safabash · 2003 [cited by applicant]
US 6641533B2 · Causey, III et al. · 2003 [cited by applicant]
US 6736797B1 · Larsen et al. · 2004 [cited by applicant]
US 6749587B2 · Flaherty · 2004 [cited by applicant]
US 6766183B2 · Walsh et al. · 2004 [cited by applicant]
US 6801420B2 · Talbot et al. · 2004 [cited by applicant]
US 6804544B2 · Van Antwerp et al. · 2004 [cited by applicant]
US 7003336B2 · Holker et al. · 2006 [cited by applicant]
US 7029444B2 · Shin et al. · 2006 [cited by applicant]
US 7066909B1 · Peter et al. · 2006 [cited by applicant]
US 7137964B2 · Flaherty · 2006 [cited by applicant]
US 7303549B2 · Flaherty et al. · 2007 [cited by applicant]
US 7399277B2 · Saidara et al. · 2008 [cited by applicant]
US 7442186B2 · Blomquist · 2008 [cited by applicant]
US 7602310B2 · Mann et al. · 2009 [cited by applicant]
US 7647237B2 · Malave et al. · 2010 [cited by applicant]
US 7699807B2 · Faust et al. · 2010 [cited by applicant]
US 7727148B2 · Talbot et al. · 2010 [cited by applicant]
US 7785313B2 · Mastrototaro · 2010 [cited by applicant]
US 7806886B2 · Kanderian, Jr. et al. · 2010 [cited by applicant]
US 7819843B2 · Mann et al. · 2010 [cited by applicant]
US 7828764B2 · Moberg et al. · 2010 [cited by applicant]
US 7879010B2 · Hunn et al. · 2011 [cited by applicant]
US 7890295B2 · Shin et al. · 2011 [cited by applicant]
US 7892206B2 · Moberg et al. · 2011 [cited by applicant]
US 7892748B2 · Norrild et al. · 2011 [cited by applicant]
US 7901394B2 · Ireland et al. · 2011 [cited by applicant]
US 7942844B2 · Moberg et al. · 2011 [cited by applicant]
US 7946985B2 · Mastrototaro et al. · 2011 [cited by applicant]
US 7955305B2 · Moberg et al. · 2011 [cited by applicant]
US 7963954B2 · Kavazov · 2011 [cited by applicant]
US 7977112B2 · Burke et al. · 2011 [cited by applicant]
US 7979259B2 · Brown · 2011 [cited by applicant]
US 7985330B2 · Wang et al. · 2011 [cited by applicant]
US 8024201B2 · Brown · 2011 [cited by applicant]
US 8100852B2 · Moberg et al. · 2012 [cited by applicant]
US 8114268B2 · Wang et al. · 2012 [cited by applicant]
US 8114269B2 · Cooper et al. · 2012 [cited by applicant]
US 8137314B2 · Mounce et al. · 2012 [cited by applicant]
US 8181849B2 · Bazargan et al. · 2012 [cited by applicant]
US 8182462B2 · Istoc et al. · 2012 [cited by applicant]
US 8192395B2 · Estes et al. · 2012 [cited by applicant]
US 8195265B2 · Goode, Jr. et al. · 2012 [cited by applicant]
US 8202250B2 · Stutz, Jr. · 2012 [cited by applicant]
US 8207859B2 · Enegren et al. · 2012 [cited by applicant]
US 8226615B2 · Bikovsky · 2012 [cited by applicant]
US 8257259B2 · Brauker et al. · 2012 [cited by applicant]
US 8267921B2 · Yodfat et al. · 2012 [cited by applicant]
US 8275437B2 · Brauker et al. · 2012 [cited by applicant]
US 8277415B2 · Mounce et al. · 2012 [cited by applicant]
US 8292849B2 · Bobroff et al. · 2012 [cited by applicant]
US 8298172B2 · Nielsen et al. · 2012 [cited by applicant]
US 8303572B2 · Adair et al. · 2012 [cited by applicant]
US 8305580B2 · Aasmul · 2012 [cited by applicant]
US 8308679B2 · Hanson et al. · 2012 [cited by applicant]
US 8313433B2 · Cohen et al. · 2012 [cited by applicant]
US 8318443B2 · Norrild et al. · 2012 [cited by applicant]
US 8323250B2 · Chong et al. · 2012 [cited by applicant]
US 8343092B2 · Rush et al. · 2013 [cited by applicant]
US 8352011B2 · Van Antwerp et al. · 2013 [cited by applicant]
US 8353829B2 · Say et al. · 2013 [cited by applicant]
US 20070123819A1 · Mernoe et al. · 2007 [cited by applicant]
US 20100160861A1 · Causey, III et al. · 2010 [cited by applicant]
US 20200237275A1 · Feldman et al. · 2020 [cited by applicant]
US 20200237276A1 · Oja et al. · 2020 [cited by applicant]
US 20220133190A1 · Ong · 2022 [cited by applicant]
US 20220186278A1 · Liu · 2022 [cited by examiner]
US 20220338768A1 · Tsang et al. · 2022 [cited by applicant]
EP 2665827A1 · 2013 [cited by applicant]
WO 2021042033A1 · 2021 [cited by applicant]
WO 2022125537A2 · 2022 [cited by applicant]
Extended European Search Report dated Apr. 6, 2023 for EP Application No. 22209660.4. [cited by applicant]
Teymourian Hazhir et al: “Microneedle-Based Detection of Ketone Bodies along with Glucose and Lactate: Toward Real-Time Continuous Interstitial Fluid Monitoring of Diabetic Ketosis and Ketoacidosis”, Analytical Chemistr… [cited by applicant]
Extended European Search Report dated Mar. 20, 2024 for European Application No. 23205590.5. [cited by applicant]
Hatada et al: “Development of a glucose sensor employing quick and easy modification method with mediator for altering electron acceptor preference”, Bioelectrochemistry,vol. 121, Jun. 1, 2018 (Jun. 1, 2018), pp. 185-19… [cited by applicant]